Channel Therapeutics Corpora
13F holders, Q1 2025 (March 31)9holders +5
6new positions
1sold out
$1.42avg. 13F price*
At the end of Q1 2025, 9 institutions reported holding Channel Therapeutics Corpora in their 13F filings, up 5 from Q4 2024. 6 opened new positions and 1 sold out. The largest holders were Ikarian Capital, LLC ($626K), Boothbay Fund Management, LLC ($186K) and Wealth Enhancement Advisory Services, LLC ($15K).
- Company
- Channel Therapeutics Corpora
- CUSIP
- 171126105
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $828K |
| Exits | 1 | $9K |
All 13F filers, Q4 2024 → Q1 2025: 585,234 shares bought and 14,347 shares sold, net +570,887 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Ikarian Capital, LLC | 0.20% | New | 440,849 | $626K |
| Boothbay Fund Management, LLC | 0.01% | New | 130,754 | $186K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 10,400 | $15K |
| Geode Capital Management, LLC | 0.00% | New | 10,070 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +913.8% | 2,565 | $4K |
| UBS Group AG | 0.00% | New | 995 | $1K |
| Tradewinds Capital Management, LLC | 0.00% | New | 200 | $284 |
| Barclays PLC | 0.00% | New | 54 | $77 |
| Bank of America Corp. | 0.00% | No change | 12 | $17 |
"% of holder's portfolio" is CHANNEL THERAPEUTICS CORPORA's weight in each manager's 13F, not the share of Channel Therapeutics Corpora the manager owns.